Roche NimbleGen and Affymetrix Expand Licensing Agreement

News

Published: March 17, 2008

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "Roche NimbleGen and Affymetrix Expand Licensing Agreement"

First Name*

Last Name*

Email Address*

Country*

Company Type*

Job Function*

Would you like to receive further email communication from Technology Networks?

Listen with

Speechify

0:00

Thank you. Listen to this article using the player above. ✖

Read time:

Roche NimbleGen Inc., a company of Roche Applied Science, and Affymetrix Inc. announced that they have expanded the terms of the license to a number of Affymetrix patents originally granted in October 2006.

The expanded license now provides certain diagnostic rights for array-based DNA copy number analysis and array-based re-sequencing in addition to covering the manufacture, use and sale of nucleic acid microarrays and related products and services in the research field. Financial details of the expanded license were not disclosed.

Genomics Research

Genomics Research

Roche NimbleGen and Affymetrix Expand Licensing Agreement